Innophos Holdings (Innophos Holdings) Total Inventories : $170.3 Mil (As of Sep. 2019)

View and export this data going back to 2006. Start your Free Trial

What is Innophos Holdings Total Inventories?

Innophos Holdings's total inventories for the quarter that ended in Sep. 2019 was $170.3 Mil. Innophos Holdings's average total inventories from the quarter that ended in Jun. 2019 to the quarter that ended in Sep. 2019 was $171.4 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Innophos Holdings's Net-Net Working Capital per share for the quarter that ended in Sep. 2019 was $-17.39.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Innophos Holdings's Days Inventory for the three months ended in Sep. 2019 was 99.80.

Inventory Turnover measures how fast the company turns over its inventory within a year. Innophos Holdings's Inventory Turnover for the quarter that ended in Sep. 2019 was 0.91.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Innophos Holdings's Inventory-to-Revenue for the quarter that ended in Sep. 2019 was 0.91.

Innophos Holdings Total Inventories Historical Data

The historical data trend for Innophos Holdings's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innophos Holdings Total Inventories Chart

Innophos Holdings Annual Data

Trend

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Total Inventories

Get a 7-Day Free Trial

184.62

172.67

128.30

145.69

180.20

Innophos Holdings Quarterly Data
	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19
Total Inventories	Get a 7-Day Free Trial															168.75	180.20	173.56	172.46	170.29

Innophos Holdings Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Innophos Holdings (NAS:IPHS) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Innophos Holdings's Net-Net Working Capital Per Share for the quarter that ended in Sep. 2019 is

	Net-Net Working Capital Per Share (Q: Sep. 2019 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(30.731	+	0.75 * 106.219	+	0.5 * 170.29	-	537.946
-	0	-	0)	/	19.6908
=	-17.39

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Innophos Holdings's Days Inventory for the three months ended in Sep. 2019 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Sep. 2019 )	/	Cost of Goods Sold (Q: Sep. 2019 )	*	Days in Period
	=	171.3725	/	156.685	*	365 / 4
	=	99.80

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Innophos Holdings's Inventory Turnover for the quarter that ended in Sep. 2019 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Sep. 2019 )	/	Average Total Inventories (Q: Sep. 2019 )
	=	156.685	/	171.3725
	=	0.91

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Innophos Holdings's Inventory to Revenue for the quarter that ended in Sep. 2019 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Sep. 2019 )	/	Revenue (Q: Sep. 2019 )
	=	171.3725	/	189.349
	=	0.91

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Innophos Holdings Total Inventories Related Terms

Thank you for viewing the detailed overview of Innophos Holdings's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

Innophos Holdings (Innophos Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Innophos Holdings Inc (NAS:IPHS) » Definitions » Total Inventories

Comparable Companies

Traded in Other Exchanges

N/A

Address

259 Prospect Plains Road, Cranbury, NJ, USA, 08512

Website

http://www.innophos.com

Innophos Holdings Inc is a holding company that manufactures and sells through its subsidiaries a variety of ingredients used in the production of food, beverages, dietary supplements, pharmaceuticals, and oral care products. Innophos ingredients are made primarily from specialty phosphates. The company organizes itself into three segments namely Food, Health and Nutrition; Industrial Specialties and Other. The Food, Health and Nutrition segment contribute the maximum revenue. The company operates in U.S., Canada, Mexico and other countries.

Executives

John M Steitz	director	ALBEMARLE CORP, 451 FLORIDA ST, BATON ROUGE LA 70801
Kim Ann Mink	director, officer: Chairman, CEO, President	259 PROSPECT PLAINS RD., BLDG A, CRANBURY NJ 08512
Gary A Cappeline	director	50 E RIVERCENTER BLVD, COVINGTON KY 41012
Karen R Osar	director	C/O WESTVACO CORP, ONE HIGH RIDGE PARK, STAMFORD CT 06905
Mark Santangelo	officer: Sr. VP, Mfg, Eng & EH&S	15710 JOHN F. KENNEDY BLVD., SUITE 300 HOUSTON TX 77032
Peter T Thomas	director	1000 LAKESIDE AVENUE, CLEVELAND OH 44114
Hermanus Kieftenbeld	officer: Senior VP and CFO	259 PROSPECT PLAINS RD., BLDG A, CRANBURY NJ 08512
James P. Zallie	director	5 WESTBROOK CORPORATE CENTER, WESTCHESTER IL 60154
Randy Gress	director, officer: CEO	259 PROSPECT PLAINS ROAD, P O BOX 8000, CRANBURY NJ 08512-8000
Stephen M Zide	director	BAIN CAPITAL PARTNERS, JOHN HANCOCK TOWER, 200 CLARENDON STREET, BOSTON MA 02116
Richard Heyse	officer: VP-Chief Financial Officer	259 PROSPECT PLAINS ROAD, BUILDING G, P O BOX 8000, CRANBURY NJ 08512-8000
Bain Capital Investors Llc	10 percent owner	200 CLARENDON STREET, BOSTON MA 02116
Bain Capital Partners Vii Lp	10 percent owner	JOHN HANCOCK TOWER, 200 CLARENDON STREET, BOSTON MA 02116
Bain Capital Fund Vii Llc	10 percent owner	JOHN HANCOCK TOWER, 200 CLARENDON STREET, BOSTON MA 02116
Bain Capital Fund Vii Lp	10 percent owner	JOHN HANCOCK TOWER, 200 CLARENDON STREET, BOSTON MA 02116